M. Hérin

610 total citations
11 papers, 514 citations indexed

About

M. Hérin is a scholar working on Immunology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, M. Hérin has authored 11 papers receiving a total of 514 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Immunology, 2 papers in Surgery and 2 papers in Pathology and Forensic Medicine. Recurrent topics in M. Hérin's work include Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). M. Hérin is often cited by papers focused on Immunotherapy and Immune Responses (2 papers), T-cell and B-cell Immunology (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). M. Hérin collaborates with scholars based in Belgium, Germany and United Kingdom. M. Hérin's co-authors include P. Weynants, Thierry Boon, Cendrine Lemoine, René Devos, A. Knuth, Aline Van Pel, R Fauchet, Alexander Knuth, Philippe Hainaut and Karin Orscheschek and has published in prestigious journals such as Blood, International Journal of Cancer and Bioorganic & Medicinal Chemistry.

In The Last Decade

M. Hérin

10 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Hérin Belgium 6 418 206 141 84 44 11 514
RP Nordan United States 7 250 0.6× 217 1.1× 158 1.1× 37 0.4× 52 1.2× 8 457
Jill Weisenbach United States 6 238 0.6× 183 0.9× 165 1.2× 73 0.9× 28 0.6× 13 370
Doug Joshua Australia 9 324 0.8× 224 1.1× 201 1.4× 33 0.4× 25 0.6× 14 558
Jutta Schröder Germany 9 241 0.6× 133 0.6× 64 0.5× 57 0.7× 29 0.7× 10 342
Carli N Greenfield United States 4 524 1.3× 469 2.3× 176 1.2× 35 0.4× 29 0.7× 7 732
Diane Razanajaona France 11 323 0.8× 95 0.5× 171 1.2× 50 0.6× 91 2.1× 15 486
Hans G. Drexler Germany 9 150 0.4× 154 0.7× 180 1.3× 150 1.8× 32 0.7× 11 485
Theo Nicholaou Australia 5 357 0.9× 259 1.3× 107 0.8× 16 0.2× 23 0.5× 6 431
Julia Cantón Spain 10 255 0.6× 186 0.9× 87 0.6× 49 0.6× 9 0.2× 20 390
E. Yuen Australia 9 209 0.5× 102 0.5× 70 0.5× 21 0.3× 22 0.5× 21 326

Countries citing papers authored by M. Hérin

Since Specialization
Citations

This map shows the geographic impact of M. Hérin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Hérin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Hérin more than expected).

Fields of papers citing papers by M. Hérin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Hérin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Hérin. The network helps show where M. Hérin may publish in the future.

Co-authorship network of co-authors of M. Hérin

This figure shows the co-authorship network connecting the top 25 collaborators of M. Hérin. A scholar is included among the top collaborators of M. Hérin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Hérin. M. Hérin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hérin, M., et al.. (1997). [Aspergillus prostatitis and prolonged corticotherapy. Apropos of a case report].. PubMed. 65(1). 43–8. 4 indexed citations
2.
Bovy, Philippe R., F. S. TJOENG, Thomas E. Rogers, et al.. (1994). Design of orally active, non-peptide fibrinogen receptor antagonists. An evolutionary process from the RGD sequence to novel anti-platelet aggregation agents. Bioorganic & Medicinal Chemistry. 2(9). 881–895. 10 indexed citations
3.
Hérin, M., et al.. (1992). Overwhelming septicaemia due to Streptococcus pneumoniae: unexpected autopsy findings. Histopathology. 20(1). 84–86. 1 indexed citations
4.
Merz, Hartmut, Karin Orscheschek, Jean‐Christophe Renauld, et al.. (1991). Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 78(5). 1311–1317. 140 indexed citations
5.
Merz, Hartmut, Karin Orscheschek, Jean‐Christophe Renauld, et al.. (1991). Interleukin-9 expression in human malignant lymphomas: unique association with Hodgkin's disease and large cell anaplastic lymphoma. Blood. 78(5). 1311–1317. 13 indexed citations
6.
Hainaut, Philippe, M. Hérin, Alexander Knuth, et al.. (1989). Presence on a human melanoma of multiple antigens recognized by autologous CTL. International Journal of Cancer. 44(4). 634–640. 154 indexed citations
7.
Hérin, M. & J. Haot. (1989). Les polypes fibroïdes inflammatoires du tube digestif. Acta Endoscopica. 19(1). 11–17.
8.
Hérin, M., Cendrine Lemoine, P. Weynants, et al.. (1987). Production of stable cytolytic T‐cell clones directed against autologous human melanoma. International Journal of Cancer. 39(3). 390–396. 182 indexed citations
9.
Closset, Jean, et al.. (1986). [Sacral chordoma, a rare tumor].. PubMed. 86(3). 163–5. 1 indexed citations
10.
Hérin, M., et al.. (1984). Metabolism of a New Antiepileptic Drug (milacemide) in the Brain. Digital Access to Libraries. 270(1). 169–169. 4 indexed citations
11.
Roba, J., et al.. (1983). Suloctidil: Relationship between pharmacokinetics and antithrombotic effect. Thrombosis Research. 29. 113–118. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026